These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4348345)

  • 1. Effects of a false neurotransmitter, p-hydroxynorephedrine, on the function of adrenergic neurons in hypertensive patients.
    Rangno RE; Kaufmann JS; Cavanaugh JH; Island D; Watson JT; Oates J
    J Clin Invest; 1973 Apr; 52(4):952-60. PubMed ID: 4348345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic adrenergic changes during submaximal exercise and in the recovery period in man.
    Pequignot JM; Peyrin L; Mayet MH; Flandrois R
    J Appl Physiol Respir Environ Exerc Physiol; 1979 Oct; 47(4):701-5. PubMed ID: 511676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amphetamine on the pressor response to tyramine: formation of p-hydroxynorephedrine from amphetamine in man.
    Cavanaugh JH; Griffith JD; Oates JA
    Clin Pharmacol Ther; 1970; 11(5):656-64. PubMed ID: 5455630
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of reserpine and guanethidine treatment on urinary catecholamines and metabolites in chronic hypertensive dogs.
    Moerman EJ; de Schaepdryver AF
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:310-. PubMed ID: 5052484
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary monoamines and monoamine metabolites in subtypes of unipolar depressive disorder and normal controls.
    Roy A; Pickar D; Douillet P; Karoum F; Linnoila M
    Psychol Med; 1986 Aug; 16(3):541-6. PubMed ID: 3763772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of occupational exposure to polychlorinated biphenyls on urinary metabolites of neurotransmitters: A cross-sectional and longitudinal perspective.
    Putschögl FM; Gaum PM; Schettgen T; Kraus T; Gube M; Lang J
    Int J Hyg Environ Health; 2015 Jul; 218(5):452-60. PubMed ID: 25869187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in urinary excretion of catecholamines and their metabolites in pediatric dental patients.
    Sakuma N; Nagasaka N
    ASDC J Dent Child; 1996; 63(2):118-22. PubMed ID: 8708120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of disulfiram on the urinary excretion of catecholamine metabolites in alcoholic males.
    Robins AH; Barron JL
    S Afr Med J; 1983 Jan; 63(2):41-2. PubMed ID: 6849160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of urinary monoamine and metabolite output measurements in depressed patients.
    Linnoila M; Karoum F; Miller T; Potter WZ
    Am J Psychiatry; 1983 Aug; 140(8):1055-7. PubMed ID: 6191580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aging on catecholamine metabolism.
    Hoeldtke RD; Cilmi KM
    J Clin Endocrinol Metab; 1985 Mar; 60(3):479-84. PubMed ID: 3972962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of clonidine on central and peripheral nerve tone in primary hypertension.
    Sullivan PA; De Quattro V; Foti A; Curzon G
    Hypertension; 1986 Jul; 8(7):611-7. PubMed ID: 3721561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients.
    Greenspan K; Schildkraut JJ; Gordon EK; Levy B; Durell J
    Arch Gen Psychiatry; 1969 Dec; 21(6):710-6. PubMed ID: 4901154
    [No Abstract]   [Full Text] [Related]  

  • 13. Sympathetic reactivity to upright posture in borderline and established hypertension.
    Januszewicz W; Sznajderman M; Wocial B; Chodakowska J; Feltynowski T; Zukowska-Grójec Z
    Cor Vasa; 1982; 24(6):429-40. PubMed ID: 7184697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of norepinephrine turnover by serotonergic drug in man.
    Rudorfer MV; Scheinin M; Karoum F; Ross RJ; Potter WZ; Linnoila M
    Biol Psychiatry; 1984 Feb; 19(2):179-93. PubMed ID: 6201198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of D, L-3H-norepinephrine in essential hypertension.
    Gitlow S; Dziedzic S; Dziedzic L; Roubein I
    Clin Exp Hypertens (1978); 1981; 3(5):897-918. PubMed ID: 7026196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma catecholamines and urinary excretion of their main metabolites in three models of portal hypertension.
    Rodríguez-Puyol D; Alsasua A; Santos JC; Blanchart A; López-Novoa JM
    Clin Physiol Biochem; 1988; 6(6):301-9. PubMed ID: 3208482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans.
    Alonso R; Gibson CJ; Wurtman RJ; Agharanya JC; Prieto L
    Biol Psychiatry; 1982 Jul; 17(7):781-90. PubMed ID: 7115832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary catecholamine metabolites and effects of clonidine in patients with alcohol amnestic disorder.
    Martin PR; Ebert MH; Gordon EK; Kopin IJ
    Clin Pharmacol Ther; 1983 Jan; 33(1):19-27. PubMed ID: 6848295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased catecholamine output in the hypertensive fawn-hooded rat.
    Magro AM; Rudofsky UH; Gilboa N; Seegal R
    Lab Anim Sci; 1986 Dec; 36(6):646-9. PubMed ID: 3821054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma.
    Candito M; Soler C; Deville A; Bekri S; Chambon P; Thyss A
    Med Pediatr Oncol; 1996 Jan; 26(1):57-60. PubMed ID: 7494513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.